Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 May;46(5):614–622. doi: 10.1165/rcmb.2011-0359OC

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2012 by the American Thoracic Society

PMC Copyright notice

Figure 5. — Effects of t-TUCB and Rolipram on pulmonary function in the lung. (A) Total respiratory resistance (R) and (B) elastance (E), (C) compliance (C), (D) central airway resistance (Rn), (E) tissue damping (G), and (F) elastance (H) are shown. Data are expressed as means ± SEM for 4–8 animals/group. *P < 0.05, TS–exposed groups were significantly different from the control group. ^†P < 0.05, treatment group with sEHI t-TUCB was significantly different from the TS vehicle group. ^‡P < 0.05, treatment group with Rolipram was significantly different from the TS vehicle group.